Environmental Engineering Reference
In-Depth Information
References
1. Gatti A, Puntes V (2009) While scientists are still wondering, industry is already selling.
NanoNow 12:28-30
2. Report of joint FAO/WHO expert meeting on the application of nanotechnologies in the food
and agriculture sectors: potential food safety implications 1-5 June 2009. pp. 1-133. http://
www.who.int/foodsafety/fs_management/meetings/nano_june09/en/index.html
3. http://www.anh-usa.org/fda-declares-silver-has-no-therapeutic-value/
4. Colvin V-L (2003) The potential environmental impact of engineered nanomaterials. Nat
Biotechnol 21:1166-1170
5. Kreyling W-G, Scheuch G (2000) In: Gehr P, Heyder J (eds) Clearance of particles deposited
in the lungs. Marcel Dekker Inc., New York. pp. 323-376
6. Schlesinger RB, Ben-Jebria A, Dahl AR, Snipes MB, Ultman J (1997) In: Massaro EJ
(ed) Disposition of inhaled toxicants. CRC, New York. pp. 493-550
7. Ballestri M, Baraldi A, Gatti AM, Furci L, Bagni A, Loria P, Rapana RM, Carulli N, Albertazzi
A (2001) Liver and kidney foreign bodies granulomatosis in a patient with malocclusion,
bruxism, and worn dental prostheses. Gastroenterology 121:1234-1238
8. Gatti A, Montanari S, Gambarelli A, Capitani F, Salvatori R (2005) In-vivo short- and long-
term evaluation of the interaction material-blood. J Mater Sci Mater Med 16:1213-1219
9. Gatti A, Montanari S (2008) Nanopathology: The health impact of nanoparticles. PanStanford
Publishing Pte. Ltd, Singapore, pp 1-298
10. Nemmar A, Hoet P-H, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts M-F,
Vanbilloen H, Mortelmans L, Nemery B (2002) Passage of inhaled particles into the blood
circulation in humans. Circulation 105(4):411-4
11. Gatti A, Rivasi F (2002) Biocompatibility of micro- and nanoparticles. Part I: in liver and
kidney. Biomaterials 23:2381-2387
12. Gatti A (2004) Biocompatibility of micro- and nano-particles in the colon. Part II. Biomaterials
25:385-392
13. Oberdorster G, Oberdorster E, Oberdorster J (2005) Nanotoxicology: An emerging discipline
evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839
14. Gatti A, Quaglino D, Sighinolfi GL (2009) A morphological approach to monitor the
nanoparticle-cell interaction. Int J Imaging 2(S09):2-21 (Editorial 1)
15. AshaRani PV, Low Kah Mun G, Prakash Hande M, Valiyaveettil S (2009) Cytotoxicity and
genotoxicity of silver nanoparticles in human cells. ACS Nano 3(2):279-290
16. Shacter E , Weitzman SA (2002) Chronic inflammation and cancer oncology (review article).
January http://www.cancernetwork.com/review-article/chronic-inflammation-and-cancer
17. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867
18. Protecting the nanotechnology workforce: NIOSH nanotechnology research and guidance
strategic plan (2013-2016)
19. http://www.nanowerk.com/nanotechnology-news/newsid
ΒΌ
35536.php
Search WWH ::




Custom Search